Showing 1021-1030 of 5301 results for "".
FDA Warns on Expression; Lilly's Ixekizumab Data Promising
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-fda-warns-on-expression-lilly-s-ixekizumab-data-promising/19093/Lilly's Ixekizumab phase III data look good for psoriasis, and the FDA warns on improper use of Expression hyaluronic acid as a dermal filler. Plus, Sitavig is available for herpes labialis, and Syneron's laser gets an onychomycosis clearance.Skincare for Men
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skincare-for-men/19108/Joel L. Cohen, MD talks about the growth in male demand for cosmetics and talks about tips for skincare for men. Male PatientsDermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.Why Lutronic
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/why-lutronic/19188/Established in 1997 by a group of accomplished scientists and prominent members of the medical community, LUTRONIC is passionate about improving the lives of physicians and their patients by developing solutions that are intuitive, versatile, and efficacious. Our customers choose our systems becauseLink Building Basics, an Ekwa.com Educational Video
https://practicaldermatology.com/topics/practice-management/link-building-basics-understanding-the-need-for-a-robust-linkbuilding-program/19331/Link building is all about getting other websites across the Internet "link back" to your website. Backlinks are Google's way of measuring the quality and popularity of your website based on the recommendation of others. Visit Ekwa.com for more information.Fillers and Cosmetic Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fillers-and-cosmetic-procedures/19367/Hayes B. Gladstone, MD discusses emerging options in the field of cosmetic dermatology, including new devices and injectables.Leaders in Dermatology
https://practicaldermatology.com/conferences/noah-worcester/leaders-in-dermatology/57075/Lawrence Green, MD, explains what makes the Noah Worcester Dermatological Society’s Annual Meeting unique and what some of the highlights of the 2026 meeting were.How to Humanize Medicine
https://practicaldermatology.com/conferences/noah-worcester/how-to-humanize-medicine/57074/Michael Greenberg, MD, discusses his presentation, “What I Would Teach Residents – Humanizing Medicine,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting."Ask Me Anything" Mentorship Session With Dr. Sheila Barbarino
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-sheila-barbarino/39880/Sheila Barbarino, MD, FACS, discusses the keys to her success using social media as a marketing tool for her practice, critical practice management issues, and more. YoungMD Connect is an editorially independent platform made possible by industry sponsorships. We would like to thank our gold platfDermwireTV: Deucravacitinib Maintains Efficacy in PsO at 3 Years
https://practicaldermatology.com/programs/practical-dermatology/dermwiretv-deucravacitinib-maintains-efficacy-in-pso-at-3-years/37249/In this episode of DermwireTV, deucravacitinib maintains efficacy for plaque psoriasis through 3 years in a new analysis; GLP-1 medications may be fueling a rise in aesthetic procedures, according to new research; and Drs. Tina Bhutani and Lisa Swanson weigh in on transitioning from academia to priv